Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-05-17 @ 8:23 PM
Study NCT ID:
NCT00887120
Status:
COMPLETED
Last Update Posted:
2020-07-17
First Post:
2009-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Reduction of Lopinavir in Children
Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Second line treatment | View |
| None | therapeutic drug monitoring | View |
| None | Asia | View |
| None | LPV | View |
| None | children | View |
| None | pharmacokinetic | View |
| None | To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir … | View |
| None | To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based … | View |